Trial · NCT00907738
Adverse events207
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 207
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 001 (Vorinostat 400 mg Once Daily [QD]) | 3 | 13 | 4 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 006 (Vorinostat 200 mg Twice Daily [BID]) | 0 | 1 | 0 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 008 (Vorinostat 400 mg Once Daily [QD]) | 0 | 7 | 0 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 012 (Vorinostat 400 mg Once Daily [QD] 7/21) | 0 | 1 | 0 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 012 (Vorinostat 300 mg Twice Daily [BID] 3/7) | 0 | 1 | 0 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 012 (Vorinostat 300 mg Once Daily [QD] 14/21) | 0 | 1 | 0 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 012 (Vorinostat 300 mg Once Daily [QD] 7/21) | 0 | 1 | 0 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 013 (Vorinostat 200 mg Twice Daily [BID] 14/21) | 1 | 1 | 1 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Base Protocol 013 (Vorinostat 300 mg Twice Daily [BID] 3/7) | 0 | 1 | 0 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 001 (Vorinostat 400 mg Once Daily [QD]) | 0 | 13 | 0 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 006 (Vorinostat 200 mg Twice Daily [BID]) | 0 | 1 | 0 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 008 (Vorinostat 400 mg Once Daily [QD]) | 1 | 7 | 1 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 012 (Vorinostat 400 mg Once Daily [QD] 7/21) | 0 | 1 | 0 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 012 (Vorinostat 300 mg Twice Daily [BID] 3/7) | 0 | 1 | 0 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 012 (Vorinostat 300 mg Once Daily [QD] 14/21) | 0 | 1 | 0 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 012 (Vorinostat 300 mg Once Daily [QD] 7/21) | 0 | 1 | 0 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 013 (Vorinostat 200 mg Twice Daily [BID] 14/21) | 0 | 1 | 0 |
| other | Abdominal pain lower | Gastrointestinal disorders | Base Protocol 013 (Vorinostat 300 mg Twice Daily [BID] 3/7) | 0 | 1 | 0 |
| other | Constipation | Gastrointestinal disorders | Base Protocol 001 (Vorinostat 400 mg Once Daily [QD]) | 1 | 13 | 1 |
| other | Constipation | Gastrointestinal disorders | Base Protocol 006 (Vorinostat 200 mg Twice Daily [BID]) | 0 | 1 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00907738/events